Suchergebnisse - "Engel, Christoph"

PubPharm (45)

1

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation

enthalten in: Journal of the National Cancer Institute | 2023

von van Barele, M. | Akdeniz, D. | Heemskerk-Gerritsen, B. | +34

CommentIn: J Natl Cancer Inst. 2023 Aug 21;:. - PMID 37603726

2

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2 : the BRCA1 and BRCA2 Cohort Consortium

enthalten in: Breast cancer research : BCR | 2023

von Kast, K. | John, E. | Hopper, J. | +51

3

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

enthalten in: British journal of cancer | 2023

von O'Mahony, D. | Ramus, S. | Southey, M. | +96

4

A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants : application to BRCA1 and BRCA2

enthalten in: Human mutation | 2023

von Zanti, M. | O'Mahony, D. | Parsons, M. | +98

5

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

enthalten in: Communications biology | 2022

von Hakkaart, C. | Pearson, J. | Marquart, L. | +98

6

Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers

enthalten in: BMC cancer | 2022

von Borde, J. | Laitman, Y. | Blümcke, B. | +21

7

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Li, S. | Silvestri, V. | Leslie, G. | +98

CommentIn: J Clin Oncol. 2022 Aug 1;40(22):2508. - PMID 35549390

8

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers : Absolute Cancer Risks and Benefits

enthalten in: Journal of the National Cancer Institute | 2022

von Schrijver, L. | Mooij, T. | Pijpe, A. | +16

CommentIn: J Natl Cancer Inst. 2022 Apr 11;114(4):483-484. - PMID 35048983

9

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

enthalten in: Journal of the National Cancer Institute | 2022

von Barnes, D. | Silvestri, V. | Leslie, G. | +99

CommentIn: J Urol. 2022 Mar;207(3):735-738. - PMID 34915718

10

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2022

von Li, H. | Engel, C. | de la Hoya, M. | +60

ErratumIn: Genet Med. 2022 Oct;24(10):2208. - PMID 36205748

1
2
3
4
5
Nächster »
[5]